Dovramilast

CAS No. 340019-69-4

Dovramilast( —— )

Catalog No. M35691 CAS No. 340019-69-4

Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor that reduces the production of pro-inflammatory mediators and cytokines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 192 In Stock
5MG 297 In Stock
10MG 471 In Stock
25MG 877 In Stock
50MG 1371 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dovramilast
  • Note
    Research use only, not for human use.
  • Brief Description
    Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor that reduces the production of pro-inflammatory mediators and cytokines.
  • Description
    Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor and can reduce the inflammatory response and improves Isoniazid (INH)-mediated bacillary clearance from the lungs. Dovramilast, as an adjunct, is used for the research of tuberculosis (TB).
  • In Vitro
    ——
  • In Vivo
    Dovramilast (oral gavage, 5, 25, or 50 mg/kg, single) significantly improves antibiotic-mediated bacterial killing and reduces lung pathology. Pharmacokinetic Parameters of Dovramilast in B6D2F1 mice.Animal Model:B6D2F1 mice Dosage:5, 25, or 50 mg/kg Administration:oral, 5, 25, or 50 mg/kg, single Result:Reduced PDE4 expression in mtb-infected mouse lungs.Animal Model:B6D2F1 mice Dosage:5, 25, or 50 mg/kg Administration:oral gavage, 5, 25, or 50 mg/kg, single Result:Improved antibiotic-mediated bacterial killing and reduced lung pathology.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    340019-69-4
  • Formula Weight
    472.55
  • Molecular Formula
    C24H28N2O6S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (52.90 mM; Ultrasonic (<60°C)
  • SMILES
    CCOc1cc(ccc1OC)[C@@H](CS(C)(=O)=O)N1Cc2cccc(NC(=O)C3CC3)c2C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.
molnova catalog
related products
  • Mirodenafil

    Mirodenafil is a PDE-5 inhibitor developed for the treatment of erectile dysfunction.The pharmacoki-netics of mirodenafil were not significantly altered by this concurrent administration. Mirodenafil (50 or 100 mg), obviously improved erectile function and was well tolerated in a representative population of Korean men with broad-spectrum ED of various etiologies and severities.

  • NSP-805

    NSP-805 is a potent and selective guinea pig cardiac phosphodiesterase 3 (PDE3) inhibitor.

  • EMD57439

    EMD57439 is a selective PDE-III inhibitor, showing no significant increase in c-AMP concentration and producing little change in Ca(50).